New imaging agent could spot rare heart disease earlier

NCT ID NCT07232459

First seen Nov 18, 2025 · Last updated Jun 12, 2026 · Updated 25 times

Summary

This study is testing a new radioactive tracer called [18F]FT8 for PET/CT scans to see if it can safely and clearly show amyloid deposits in organs, especially the heart. Researchers will compare the scans to standard tests like echocardiograms and MRIs. The study involves 20 people with amyloidosis and 5 healthy volunteers to see how well the tracer works for diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of University of Science and Technology of China

    RECRUITING

    Hefei, Anhui, 230000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Tianjin Medical University General Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 350005, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.